Alphagan P



Indications and Reactions:

Role Indications Reactions
Primary
Glaucoma 35.8%
Product Used For Unknown Indication 16.2%
Drug Use For Unknown Indication 15.2%
Intraocular Pressure Increased 7.4%
Hypertension 5.5%
Supplementation Therapy 2.4%
Dry Eye 2.0%
Blood Cholesterol Increased 1.7%
Hypothyroidism 1.7%
Dry Eyes 1.3%
Increased Intraocular Pressure 1.3%
Intraocular Pressure 1.3%
Diabetes Mellitus 1.2%
Open Angle Glaucoma 1.2%
Postoperative Care 1.2%
Diabetes 1.1%
Arthritis 0.9%
Blood Pressure 0.9%
Ocular Hypertension 0.9%
Gastrooesophageal Reflux Disease 0.8%
Ocular Hyperaemia 24.2%
Vision Blurred 12.1%
Scleral Hyperaemia 7.7%
Inappropriate Schedule Of Drug Administration 6.6%
Eye Irritation 4.9%
Intraocular Pressure Increased 4.9%
Drug Ineffective 4.4%
Somnolence 4.4%
Dry Mouth 3.3%
Therapeutic Response Decreased 3.3%
Visual Impairment 3.3%
Eye Pain 2.7%
Lacrimation Increased 2.7%
Visual Acuity Reduced 2.7%
Eye Pruritus 2.2%
Headache 2.2%
Nausea 2.2%
Photophobia 2.2%
Syncope 2.2%
Anaphylactic Reaction 1.6%
Secondary
Glaucoma 46.0%
Drug Use For Unknown Indication 10.3%
Product Used For Unknown Indication 8.3%
Intraocular Pressure Increased 5.6%
Supplementation Therapy 5.2%
Hypertension 4.8%
Open Angle Glaucoma 3.2%
Intraocular Pressure 2.4%
Hypothyroidism 2.0%
Blood Cholesterol Increased 1.6%
Dry Eye 1.6%
Increased Intraocular Pressure 1.6%
Postoperative Care 1.6%
Dry Eyes 1.2%
Blood Pressure Increased 0.8%
Breast Lump Removal 0.8%
Diabetes 0.8%
Eye Infection Bacterial 0.8%
Intraocular Pressure Test 0.8%
Intraocular Pressure Test Abnormal 0.8%
Ocular Hyperaemia 12.9%
Intraocular Pressure Increased 11.3%
Vision Blurred 11.3%
Lacrimation Increased 6.5%
Eye Irritation 4.8%
Medication Error 4.8%
Swelling Face 4.8%
Visual Acuity Reduced 4.8%
Visual Field Defect 4.8%
Death 3.2%
Dry Mouth 3.2%
Headache 3.2%
Inappropriate Schedule Of Drug Administration 3.2%
Myopia 3.2%
Psychotic Disorder 3.2%
Skin Discolouration 3.2%
Somnolence 3.2%
Sudden Visual Loss 3.2%
Therapeutic Response Decreased 3.2%
Asthenia 1.6%
Concomitant
Product Used For Unknown Indication 29.3%
Glaucoma 21.6%
Drug Use For Unknown Indication 9.3%
Hypertension 4.5%
Osteoporosis 3.7%
Muscle Spasms 2.9%
Cardiac Disorder 2.5%
Diabetes Mellitus 2.5%
Pulmonary Arterial Hypertension 2.5%
Asthma 2.3%
Eye Disorder 2.1%
Lung Disorder 2.1%
Open Angle Glaucoma 2.1%
Toothache 2.1%
Blood Cholesterol Increased 1.9%
Multiple Sclerosis 1.9%
Pain 1.9%
Blood Cholesterol Abnormal 1.7%
Chronic Obstructive Pulmonary Disease 1.4%
Depression 1.4%
Weight Decreased 12.6%
Vomiting 11.7%
Visual Impairment 9.7%
Pneumonia 7.8%
Ocular Hyperaemia 6.8%
Death 4.9%
Eye Irritation 4.9%
Urinary Tract Infection 4.9%
Stress Fracture 3.9%
Visual Acuity Reduced 3.9%
Bladder Disorder 2.9%
Dyspnoea 2.9%
Eye Pain 2.9%
Fatigue 2.9%
Insomnia 2.9%
Intraocular Pressure Increased 2.9%
Pain In Extremity 2.9%
Partial Seizures 2.9%
Rash 2.9%
Retinal Vein Thrombosis 2.9%